Mcf Advisors LLC Viatris Inc Transaction History

Mcf Advisors LLC

$1.44 Billion
Q2 2025

A detailed history of Mcf Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Mcf Advisors LLC holds 697 shares of VTRS stock, worth $6,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares

697

Previous 694 0.43%

Holding current value

$6,558

Previous $6,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	BUY	$7.26 - $9.12 $21 - $27	3 Added 0.43%	697 $6,000
Q1 2025 May 06, 2025	BUY	$8.68 - $12.42 $312 - $447	36 Added 5.47%	694 $6,000
Q4 2024 Jan 17, 2025	BUY	$11.32 - $13.37 $1,765 - $2,085	156 Added 31.08%	658 $8,000
Q1 2024 Apr 16, 2024	SELL	$11.27 - $13.53 $957 - $1,150	-85 Reduced 14.48%	502 $5,000
Q4 2023 Feb 01, 2024	SELL	$8.77 - $10.85 $8 - $10	-1 Reduced 0.17%	587 $6,000
Q4 2022 Jan 31, 2023	SELL	$8.72 - $11.56 $279 - $369	-32 Reduced 5.16%	588 $6,000
Q3 2022 Nov 09, 2022	SELL	$8.48 - $11.13 $500 - $656	-59 Reduced 8.69%	620 $5,000
Q2 2022 Aug 11, 2022	SELL	$9.95 - $12.27 $4,019 - $4,957	-404 Reduced 37.3%	679 $7,000
Q1 2022 May 05, 2022	BUY	$9.81 - $15.4 $10,624 - $16,678	1,083 New	1,083 $11,000
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $13,286 - $16,133	-1,099 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $238 - $272	18 Added 1.67%	1,099 $15,000
Q2 2021 Aug 10, 2021	SELL	$12.97 - $16.15 $3,034 - $3,779	-234 Reduced 17.79%	1,081 $15,000
Q1 2021 May 13, 2021	SELL	$13.59 - $18.54 $9,078 - $12,384	-668 Reduced 33.69%	1,315 $18,000
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $28,356 - $37,161	1,983 New	1,983 $37,000

Others Institutions Holding VTRS

# of Institutions

1,120

Shares Held

958M

Call Options Held

4.15M

Put Options Held

2.65M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.4B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account